tenofovir has been researched along with dapivirine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 18 (66.67) | 24.3611 |
| 2020's | 8 (29.63) | 2.80 |
| Authors | Studies |
|---|---|
| Anton, P; Cranage, M; Herrera, C; McGowan, I; Shattock, RJ | 1 |
| Ariën, KK; Bizzarri, BM; Botta, M; Brai, A; Canducci, F; Cascone, L; Casian, A; Ceresola, E; Crespan, E; Dasso Lang, MC; Deodato, D; Dreassi, E; Greco, AM; Maga, G; Tintori, C; Vanham, G; Zamperini, C | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Albright, TH; Fabian, J; Gupta, KM; Johnson, TJ; Kiser, PF | 1 |
| Kaptur, PE; Mertenskoetter, T | 1 |
| Colby-Germinario, SP; Schachter, JR; Schader, SM; Wainberg, MA; Xu, H | 1 |
| Colby-Germinario, SP; Ibanescu, RI; Moisi, D; Oliveira, M; Schader, SM; Wainberg, MA | 1 |
| Moncla, BJ; Pryke, K; Rohan, LC; Yang, H | 1 |
| Szpir, M; Van Damme, L | 1 |
| McGowan, I | 1 |
| Akil, A; Cost, M; Devlin, B; Rohan, LC | 1 |
| Agashe, H; Akil, A; Devlin, B; Dezzutti, CS; Hillier, SL; Moncla, BJ; Rohan, LC; Shi, Y; Uranker, K | 1 |
| Cameron, D; Dias, N; Dreier, P; Holding, J; Holt, JD; Muntendam, A; Nuttall, J; Oostebring, F; Rohan, L | 1 |
| Cuppone, AM; De Falco, G; Ekeruche-Makinde, J; Hijazi, K; Hold, GL; Iannelli, F; Kelly, CG; Pozzi, G; Shattock, R; Smith, K; Stincarelli, MA | 1 |
| Berry, S; Ekeruche-Makinde, J; El-Omar, EM; Frank, B; Gwozdz, G; Hijazi, K; Hold, GL; Iannelli, F; Kelly, C; Mukhopadhya, I; Murray, GI; Pozzi, G; Shattock, R; Thomson, J | 1 |
| Blakney, AK; Jiang, Y; Little, AB; Woodrow, KA | 1 |
| Abdool Karim, SS; Baxter, C; Passmore, JS | 1 |
| Cameron, SA; Cheshenko, N; Frank, B; Fredricks, D; Herold, BC; Keller, MJ; Mesquita, PM; Reagle, K; Sinclair, S; Srinivasan, S; Taneva, E; Weinrick, B | 1 |
| Avenant, C; Bick, AJ; Dlamini, S; Enfield, K; Hapgood, JP; Kuipa, M; Maritz, MF; Moliki, JM; Skosana, S; van der Spuy, Z; Woodland, JG | 1 |
| Avenant, C; Dlamini, S; Enfield, K; Hapgood, JP; Kuipa, M | 1 |
| Bekker, LG; Carter, A; Craig, C; Devlin, B; Gill, K; Gwetu, T; Kotze, P; Kusemererwa, S; Louw, C; Mabude, Z; Malherbe, M; Mans, W; Moraba, R; Nel, A; Rosenberg, Z; Steytler, J; Tempelman, H; Van Baelen, B; van der Ryst, E; van Niekerk, N | 1 |
| Baeten, JM; Balán, IC; Brown, ER; Bunge, K; Chinula, L; Chirenje, ZM; Garcia, M; Gati Mirembe, B; Govender, V; Hendrix, CW; Hillier, SL; Hunidzarira, P; Jacobson, C; Jiao, Y; Jones, J; Livant, E; Makanani, B; Mansoor, LE; Mayo, AJ; Mellors, JW; Mgodi, NM; Mhlanga, F; Naidoo, L; Nair, G; Nakabiito, C; Nel, A; Ngure, K; Palanee-Phillips, T; Parikh, UM; Patterson, K; Peda, M; Ramjee, G; Rosenberg, Z; Scheckter, R; Singh, D; Singh, N; Siva, S; Soto-Torres, LE; Szydlo, DW; Taha, TE; Torjesen, K; van der Straten, A | 1 |
| Fried, JR; Fuqua, JL; Minooei, F; Palmer, KE; Steinbach-Rankins, JM | 1 |
| Mwethera, PG; Obiero, J; Ogongo, P; Wiysonge, CS | 1 |
| Akello, CA; Anderson, P; Baeten, JM; Bekker, LG; Brown, ER; Bunge, K; Celum, C; Garcia, M; Hendrix, C; Hillier, SL; Hosek, S; Jacobson, C; Johnson, S; Levy, L; Livant, E; Macdonald, P; McClure, T; Milan, G; Muhlanga, F; Nair, G; Nakabiito, C; Nakalega, R; Ngure, K; Palanee-Phillips, T; Parikh, U; Reddy, K; Rooney, JF; Siziba, B; Soto-Torres, L; Steytler, J; Szydlo, D; Tahuringana, E; van der Straten, A | 1 |
| Balkus, JE; Bunge, K; Chakhtoura, N; Chappell, CA; Fairlie, L; Gadama, L; Hillier, SL; Matrimbira, M; Mayo, AJ; Mgodi, N; Nakabiito, C; Piper, J; Richardson, B; Szydlo, DW | 1 |
5 review(s) available for tenofovir and dapivirine
| Article | Year |
|---|---|
Update on microbicide research and development - seeking new HIV prevention tools for women.
Topics: Adenine; Administration, Intravaginal; Adult; Africa South of the Sahara; Anti-HIV Agents; Anti-Infective Agents; Clinical Trials as Topic; Cyclohexanes; Drug Discovery; Female; HIV Infections; Humans; Male; Maraviroc; Organophosphonates; Pyridines; Pyrimidines; Tenofovir; Triazoles; Urea | 2011 |
Current status of topical antiretroviral chemoprophylaxis.
Topics: Adenine; Administration, Intravaginal; Administration, Topical; Anilides; Anti-HIV Agents; Chemoprevention; Clinical Trials, Phase II as Topic; Female; Furans; HIV Infections; Humans; Organophosphonates; Pyrimidines; Tenofovir; Thioamides; Treatment Outcome | 2012 |
An overview of antiretroviral pre-exposure prophylaxis of HIV infection.
Topics: Adenine; Anti-HIV Agents; Cyclohexanes; Drug Resistance, Viral; Female; HIV Infections; Humans; Male; Maraviroc; Medication Adherence; Nitriles; Organophosphonates; Pre-Exposure Prophylaxis; Pyridones; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Triazoles | 2014 |
The microbiome and HIV prevention strategies in women.
Topics: Anti-Retroviral Agents; Female; Gardnerella vaginalis; HIV Infections; Humans; Microbiota; Pre-Exposure Prophylaxis; Pyrimidines; Tenofovir; Treatment Failure; Vagina; Vaginosis, Bacterial | 2018 |
Topical microbicides for preventing sexually transmitted infections.
Topics: Acrylic Resins; Adenine; Administration, Intravaginal; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Bias; Cellulose; Female; HIV Infections; Humans; Naphthalenesulfonates; Placebos; Polymers; Pyrimidines; Seaweed; Sexually Transmitted Diseases; Tenofovir | 2021 |
4 trial(s) available for tenofovir and dapivirine
| Article | Year |
|---|---|
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Middle Aged; Patient Compliance; Patient Safety; Pyrimidines; Seroconversion; South Africa; Tenofovir; Treatment Outcome; Uganda | 2021 |
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Malawi; Patient Compliance; Patient Safety; Pyrimidines; Seroconversion; South Africa; Tenofovir; Treatment Outcome; Uganda; Zimbabwe | 2021 |
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
Topics: Adolescent; Anti-HIV Agents; Cross-Over Studies; Emtricitabine; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; South Africa; Tenofovir | 2023 |
DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.
Topics: Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Malawi; Pregnancy; Tenofovir | 2024 |
18 other study(ies) available for tenofovir and dapivirine
| Article | Year |
|---|---|
Reverse transcriptase inhibitors as potential colorectal microbicides.
Topics: Adenine; Anilides; Anti-HIV Agents; Anti-Infective Agents, Local; Colon; Drug Resistance, Viral; Furans; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Organophosphonates; Pyrimidines; Rectum; Reverse Transcriptase Inhibitors; Tenofovir; Thioamides; Tissue Culture Techniques; Virus Replication | 2009 |
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family.
Topics: Administration, Intravaginal; Anti-HIV Agents; Cell Survival; Chemistry, Pharmaceutical; DNA, Viral; Dose-Response Relationship, Drug; Drug Design; Gels; HIV-1; Models, Molecular; Molecular Docking Simulation; Pyrimidines; Reverse Transcriptase Inhibitors | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
Topics: Adenine; Administration, Intravaginal; Anti-HIV Agents; Anti-Retroviral Agents; Compressive Strength; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Organophosphonates; Polyurethanes; Pyrimidines; Tenofovir | 2010 |
Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination.
Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir | 2011 |
In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine.
Topics: Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir | 2012 |
Testing of viscous anti-HIV microbicides using Lactobacillus.
Topics: Adenine; Anilides; Animals; Anti-HIV Agents; Anti-Infective Agents, Local; Cattle; Chemokine CCL5; Colony Count, Microbial; Excipients; Female; Furans; Humans; Lactobacillus; Microbial Sensitivity Tests; Microbial Viability; Organophosphonates; Pyrimidines; Serum Albumin, Bovine; Tenofovir; Thioamides; Vagina; Viscosity | 2012 |
Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
Topics: Adenine; Administration, Intravaginal; Anti-HIV Agents; Anti-Infective Agents; Drug Delivery Systems; Female; HIV Infections; Humans; In Vitro Techniques; Membranes, Artificial; Organophosphonates; Pyrimidines; Tenofovir; Vagina | 2014 |
Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention.
Topics: Adenine; Administration, Intravaginal; Administration, Topical; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; HIV Infections; HIV-1; Humans; Organophosphonates; Polymers; Pyrimidines; Tenofovir; Vagina | 2015 |
The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Contraceptive Devices, Female; Disease Models, Animal; Drug Carriers; Female; HIV Infections; Pyrimidines; Sheep; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies | 2015 |
Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.
Topics: Adult; Anti-HIV Agents; Biological Transport; Cell Line; Cell Line, Tumor; Cervix Uteri; Darunavir; Drug Resistance; Drug Synergism; Female; Gene Expression Regulation; Humans; Membrane Transport Proteins; Middle Aged; Organ Culture Techniques; Pyrimidines; Tenofovir; Vagina | 2015 |
Antiretroviral gels: facing the FACTS.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Anti-Infective Agents, Local; Clinical Trials as Topic; Drug Delivery Systems; Female; Gels; HIV Infections; Humans; Medication Adherence; Pyrimidines; Sexual Behavior; Tenofovir; Women's Health | 2015 |
Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.
Topics: Aged; Anti-Infective Agents; Caco-2 Cells; Darunavir; Epithelial Cells; Female; Gene Expression; Gene Expression Profiling; Humans; Intestinal Mucosa; Male; Membrane Transport Proteins; Middle Aged; Pyrimidines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tenofovir | 2016 |
In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems.
Topics: Animals; Chemistry, Pharmaceutical; Cyclohexanes; Delayed-Action Preparations; Drug Delivery Systems; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Lactic Acid; Macaca nemestrina; Maraviroc; Methacrylates; Mucous Membrane; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Primates; Pyrimidines; Tenofovir; Triazoles; Vagina | 2016 |
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics.
Topics: Actinobacteria; Adenine; Alanine; Anti-Retroviral Agents; Bacteria; Endocytosis; Female; Gardnerella vaginalis; HIV Infections; Humans; Hydrogen-Ion Concentration; Jurkat Cells; Lactobacillus crispatus; Microbiota; Pyrimidines; Tenofovir; Vagina | 2018 |
Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function
Topics: Anti-Retroviral Agents; Cell Line, Tumor; Cell Survival; Humans; Inflammation; Peripheral Blood Stem Cells; Progestins; Pyrimidines; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Tenofovir; Transcription Factors | 2019 |
Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens.
Topics: Anti-HIV Agents; Binding, Competitive; Cell Line; Contraceptive Agents, Hormonal; HIV Infections; HIV-1; Humans; Immunologic Factors; In Vitro Techniques; Levonorgestrel; Maraviroc; Phosphorylation; Progesterone Congeners; Pyrimidines; Receptors, Progesterone; Tenofovir; Transcriptional Activation | 2020 |
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Cell Death; Cell Line; Drug Compounding; Drug Liberation; Drug Synergism; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lectins; Nanoparticles; Particle Size; Plant Lectins; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Raltegravir Potassium; Recombinant Proteins; Tenofovir | 2021 |